Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

Omar Qureshi(Immune Regulation (United Kingdom)), Yong Zheng(Immune Regulation (United Kingdom)), Kyoko Nakamura(Immune Regulation (United Kingdom)), Kesley Attridge(Immune Regulation (United Kingdom)), Claire N. Manzotti(Immune Regulation (United Kingdom)), Emily M. Schmidt(Immune Regulation (United Kingdom)), Jennifer Baker(Immune Regulation (United Kingdom)), Louisa Jeffery(Immune Regulation (United Kingdom)), Satdip Kaur(Immune Regulation (United Kingdom)), Zoe Briggs(Immune Regulation (United Kingdom)), Tie Zheng Hou(Immune Regulation (United Kingdom)), Clare E. Futter(University College London), Graham Anderson(Immune Regulation (United Kingdom)), Lucy S. K. Walker(Immune Regulation (United Kingdom)), David M. Sansom(Immune Regulation (United Kingdom))
Science
April 7, 2011
Cited by 1,786Open Access
Full Text

Abstract

Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an essential negative regulator of T cell immune responses whose mechanism of action is the subject of debate. CTLA-4 shares two ligands (CD80 and CD86) with a stimulatory receptor, CD28. Here, we show that CTLA-4 can capture its ligands from opposing cells by a process of trans-endocytosis. After removal, these costimulatory ligands are degraded inside CTLA-4-expressing cells, resulting in impaired costimulation via CD28. Acquisition of CD86 from antigen-presenting cells is stimulated by T cell receptor engagement and observed in vitro and in vivo. These data reveal a mechanism of immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the cell-extrinsic depletion of ligands, accounting for many of the known features of the CD28-CTLA-4 system.


Related Papers

No related papers found

Powered by citation graph analysis